Holen Sie sich die Stockscreener-App
69.00
2.72%
1.83
Corcept Therapeutics Inc Aktie (CORT) Neueste Nachrichten
What are the latest earnings results for Corcept Therapeutics IncorporatedInvest smarter with daily stock recommendations - jammulinksnews.com
CORT's Q2 Earnings Beat and Pipeline Momentum: A Case for Revisiting the Downside as a Buy Opportunity - AInvest
When is Corcept Therapeutics Incorporated stock expected to show significant growthTremendous financial leverage - jammulinksnews.com
Corcept Therapeutics (CORT): A High-Conviction Buy Amidst Breakthroughs in Cortisol-Modulating Therapies - AInvest
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q2 2025 Earnings Call Transcript - Insider Monkey
Corcept Therapeutics Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
How does Corcept Therapeutics Incorporated compare to its industry peersPost Market Picks With Low Risk - jammulinksnews.com
Published on: 2025-08-02 05:25:16 - metal.it
Corcept Therapeutics Incorporated Recovery Hinges on Volume BreakoutNews Based Entry Opportunity Alerts Detected - metal.it
CORT's Q2 Earnings Top Mark, Revenues Lag, '25 View Cut, Stock Down - TradingView
A Quick Look at Today's Ratings for Corcept Therapeutics(CORT.US), With a Forecast Between $121 to $145 - 富途牛牛
Corcept Therapeutics 2025 Q2 Earnings Misses Targets as Net Income Declines 1% - AInvest
Corcept Faces Growing Pains As Earnings Miss The Mark - Finimize
Corcept Therapeutics Q2 CY2025: Revenue Misses, Earnings BeatNews and Statistics - IndexBox
Corcept: Q2 Earnings Snapshot - Connecticut Post
Earnings call transcript: Corcept Therapeutics Q2 2025 earnings beat expectations By Investing.com - Investing.com Canada
Corcept Therapeutics (CORT) Tops Q2 Earnings Estimates - Yahoo Finance
Corcept (NASDAQ:CORT) Misses Q2 Sales Targets - Yahoo Finance
Corcept Therapeutics Reports Strong Q2 Earnings, Surpassing Analyst ExpectationsNews and Statistics - IndexBox
Corcept Therapeutics falls as revenue guidance disappoints investors By Investing.com - Investing.com Canada
CORCEPT THERAPEUTICS INC SEC 10-Q Report - TradingView
Corcept Earnings: Record Patient Growth Drives 19% Revenue Jump, Pipeline Scores Multiple Wins - Stock Titan
Insiders Favor These 3 High Growth Companies - Yahoo.co
Corcept Therapeutics Announces Q2 Financial Results and Corporate Update on July 31, 2025 - AInvest
Corcept Therapeutics' Q2 Earnings: A Critical Inflection Point for Growth and Innovation - AInvest
What To Expect From Corcept’s (CORT) Q2 Earnings - uk.finance.yahoo.com
Technical Charts Suggest Momentum Shift in Corcept Therapeutics IncorporatedSmart Allocation Stock Pick Insights Gaining Interest - metal.it
Published on: 2025-07-28 23:53:14 - metal.it
Why Corcept Therapeutics Incorporated stock attracts strong analyst attentionPortfolio Diversification Stock Ideas From Experts - beatles.ru
Why Corcept Therapeutics Incorporated stock attracts strong analyst attention Daily Equity Signal Strength Summary Report - metal.it
What are the technical indicators suggesting about Corcept Therapeutics IncorporatedInvest confidently with professional market insights - jammulinksnews.com
H.C. Wainwright Remains Bullish on Corcept Therapeutics Incorporated (CORT) - Yahoo Finance
Why is Corcept Therapeutics Incorporated stock attracting strong analyst attentionFree Investment Community - jammulinksnews.com
Corcept Therapeutics Advances Pipeline Fueling Growth With Controlled Risk - Yahoo Finance
10 Most Profitable Biotech Stocks to Invest in Now - Insider Monkey
Corcept Therapeutics’ ALS Study: A Potential Game-Changer? - TipRanks
Should I buy Corcept Therapeutics Incorporated stock before earningsHigh-octane financial growth - jammulinksnews.com
Is Corcept Therapeutics Incorporated a good long term investmentConsistent high-performance stocks - PrintWeekIndia
What drives Corcept Therapeutics Incorporated stock priceUnbelievable profit margins - PrintWeekIndia
What analysts say about Corcept Therapeutics Incorporated stockExceptional financial outcomes - Autocar Professional
Is Corcept Therapeutics Incorporated stock overhyped or has real potentialFree Market Dynamics Reports - jammulinksnews.com
Corcept (CORT) Advances Ovarian Cancer Therapy with FDA Filing for Relacorilant - Yahoo.co
Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call - Business Wire
Corcept Advances Cancer Drug as Analysts Back Strong Growth Prospects - Yahoo Finance
0.93%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):